Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,889 | -54,568 | -71,658 | -40,703 | -26,417 |
| Depreciation Amortization | -3,470 | 825 | 1,218 | 1,815 | 1,647 |
| Accounts receivable | -1,465 | 1,613 | -2,061 | 7,963 | -7,298 |
| Other Working Capital | 93,266 | 55,741 | -10,585 | -910 | 9,665 |
| Other Operating Activity | 17,108 | 7,568 | 17,203 | -1,885 | 16,728 |
| Operating Cash Flow | $36,550 | $11,179 | $-65,883 | $-33,720 | $-5,675 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -59,394 | -73,653 | 18,857 | 79,873 | -100,037 |
| PPE Investments | -43,065 | -3,751 | -732 | N/A | N/A |
| Net Acquisitions | -75,647 | N/A | N/A | -2,411 | -621 |
| Investing Cash Flow | $-178,106 | $-77,404 | $18,125 | $77,462 | $-100,658 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 231,963 | 98,144 | 1,113 | 6,804 | 106,733 |
| Other Financing Activity | -254 | -654 | -776 | 12,906 | -4,556 |
| Financing Cash Flow | $231,709 | $97,490 | $337 | $19,710 | $102,177 |
| Exchange Rate Effect | 439 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 53,326 | 22,061 | 69,482 | 6,030 | 10,186 |
| End Cash Position | 143,918 | 53,326 | 22,061 | 69,482 | 6,030 |
| Net Cash Flow | $90,592 | $31,265 | $-47,421 | $63,452 | $-4,156 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,550 | 11,179 | -65,883 | -33,720 | -5,675 |
| Capital Expenditure | -43,065 | -3,751 | -732 | 0 | 0 |
| Free Cash Flow | -6,515 | 7,428 | -66,615 | -33,720 | -5,675 |